Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 27 Mar 2026 – 20 Aug 2026, limited by Groww Nifty PSU Bank Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Nifty PSU Bank Index Fund | Nifty Bank |
|---|---|---|
| 27 Mar 2026 | ₹100.00 | ₹100.00 |
| 08 Apr 2026 | ₹105.53 | ₹106.56 |
| 20 Apr 2026 | ₹108.13 | ₹108.24 |
| 03 May 2026 | ₹102.63 | ₹104.95 |
| 15 May 2026 | ₹97.91 | ₹102.75 |
| 27 May 2026 | ₹100.27 | ₹104.93 |
| 08 Jun 2026 | ₹99.96 | ₹103.42 |
| 20 Jun 2026 | ₹106.12 | ₹110.35 |
| 02 Jul 2026 | ₹103.46 | ₹111.01 |
| 15 Jul 2026 | ₹101.36 | ₹110.49 |
| 27 Jul 2026 | ₹101.05 | ₹109.21 |
| 08 Aug 2026 | ₹106.07 | ₹110.47 |
| 20 Aug 2026 | ₹103.91 | ₹109.99 |
| Metric | Groww · Regular NAV ₹10.24 Very High risk Unrated | Category median Index Funds · 366 funds |
|---|---|---|
| — | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +3.91% | +7.40% | |
| +0.88% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 24.33% | 13.88% | |
| — | 0.25 | |
| — | 0.35 | |
| -11.95% | -16.66% | |
| Nifty Bank | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.80% | 0.96% | |
| ₹7.16Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 32% | 35% | |
| Nikhil Satam | — | |
| 27 Mar 2026 | — | |
| 12 | — | |
| 97.6% | — | |
| 1.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.